Last edition
News about "first-in-class polycythemia vera treatment"
US FDA Approves First Drug for Polycythemia Vera
The US Food and Drug Administration (FDA) has approved the first-in-class drug for polycythemia vera, targeting the underlying biology driving excessive Red Blood Cell (RBC) production.
First-in-class Polycythemia Vera Treatment | 31/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members